Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $5.00

Aveanna Healthcare (NASDAQ:AVAH) had its target price increased by UBS Group from $4.50 to $5.00 in a research report report published on Friday morning,Benzinga reports. The firm currently has a sell rating on the stock.

Separately, Truist Financial reduced their price objective on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating for the company in a report on Friday, April 11th.

Aveanna Healthcare Stock Down 1.5%

Shares of NASDAQ AVAH opened at $5.42 on Friday. The firm has a market cap of $1.06 billion, a P/E ratio of -15.94 and a beta of 2.01. Aveanna Healthcare has a twelve month low of $2.32 and a twelve month high of $6.19. The company has a 50 day moving average of $4.84 and a 200 day moving average of $4.89.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the business’s stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $5.51, for a total transaction of $339,217.64. Following the completion of the sale, the insider now owns 1,453,948 shares of the company’s stock, valued at approximately $8,011,253.48. The trade was a 4.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Over the last 90 days, insiders sold 67,412 shares of company stock worth $372,142. 7.80% of the stock is owned by insiders.

Institutional Trading of Aveanna Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. KLP Kapitalforvaltning AS purchased a new stake in shares of Aveanna Healthcare during the fourth quarter worth about $35,000. BNP Paribas Financial Markets bought a new position in shares of Aveanna Healthcare during the 4th quarter valued at approximately $35,000. Tower Research Capital LLC TRC raised its stake in shares of Aveanna Healthcare by 662.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock valued at $36,000 after acquiring an additional 6,854 shares during the period. Catalyst Funds Management Pty Ltd lifted its holdings in shares of Aveanna Healthcare by 321.4% in the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock worth $54,000 after acquiring an additional 9,000 shares during the last quarter. Finally, Sagespring Wealth Partners LLC purchased a new position in shares of Aveanna Healthcare during the 4th quarter worth about $57,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.